Cargando…
PAQR4 promotes cell proliferation and metastasis through the CDK4-pRB-E2F1 pathway in non-small-cell lung cancer
BACKGROUND: It is reported that progestin and adipoQ receptor 4 (PAQR4) has a tumorigenic effect on human breast cancer, but the role of PAQR4 in non-small-cell lung cancer (NSCLC) is unknown. The aim of this study was to investigate the role of PAQR4 in NSCLC. METHODS: Quantitative real-time PCR (q...
Autores principales: | Wu, Bin, Liu, Rongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521844/ https://www.ncbi.nlm.nih.gov/pubmed/31190865 http://dx.doi.org/10.2147/OTT.S181432 |
Ejemplares similares
-
CDK4, pRB and E2F1: connected to insulin
por: Fajas, Lluis, et al.
Publicado: (2010) -
Gestational diabetes leads to down-regulation of CDK4-pRB-E2F1 pathway genes in pancreatic islets of rat offspring
por: Nazari, Zahra, et al.
Publicado: (2017) -
KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma
por: D’Oto, Alexandra, et al.
Publicado: (2021) -
Firing of Replication Origins Is Disturbed by a CDK4/6 Inhibitor in a pRb-Independent Manner
por: Kim, Su-Jung, et al.
Publicado: (2023) -
Deregulation of the pRb-E2F4 axis alters epidermal homeostasis and favors tumor development
por: Costa, Clotilde, et al.
Publicado: (2016)